195 related articles for article (PubMed ID: 1304409)
1. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus.
Massardo L; Jacobelli S; Leissner M; González M; Villarroel L; Rivero S
Lupus; 1992 Dec; 1(6):401-5. PubMed ID: 1304409
[TBL] [Abstract][Full Text] [Related]
2. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI.
Nagasawa K; Tada Y; Koarada S; Horiuchi T; Tsukamoto H; Murai K; Ueda A; Yoshizawa S; Ohta A
Lupus; 2005; 14(5):385-90. PubMed ID: 15934439
[TBL] [Abstract][Full Text] [Related]
3. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies.
Migliaresi S; Picillo U; Ambrosone L; Di Palma G; Mallozzi M; Tesone ER; Tirri G
Lupus; 1994 Feb; 3(1):37-41. PubMed ID: 8025584
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
Ruiz-Arruza I; Ugarte A; Cabezas-Rodriguez I; Medina JA; Moran MA; Ruiz-Irastorza G
Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
[TBL] [Abstract][Full Text] [Related]
5. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.
Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K
Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI.
Nakamura J; Harada Y; Oinuma K; Iida S; Kishida S; Takahashi K
Lupus; 2010 Oct; 19(11):1307-14. PubMed ID: 20605878
[TBL] [Abstract][Full Text] [Related]
7. [Effect and limitation of intravenous methylprednisolone pulse therapy in the long-term follow-up of childhood systemic lupus erythematosus].
Yokota S; Shimizu H; Aihara Y; Mitsuda T; Ibe M; Kuriyama T; Mori T; Kosuge K
Ryumachi; 1992 Jun; 32(3):215-22. PubMed ID: 1523523
[TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
Rascu A; Manger K; Kraetsch HG; Kalden JR; Manger B
Lupus; 1996 Aug; 5(4):323-7. PubMed ID: 8869906
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic knee osteonecrosis in patients with systemic lupus erythematosus: a case-control study.
Zhao L; Wu X; Wu H; Su J; Zhang W; Zhao Y; Zhang X; Zheng W
Rheumatol Int; 2016 Aug; 36(8):1105-11. PubMed ID: 27230994
[TBL] [Abstract][Full Text] [Related]
10. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Chaudhry-Ahluwalia V; Hallet DC; Cook RJ
J Rheumatol; 2001 Apr; 28(4):761-5. PubMed ID: 11327247
[TBL] [Abstract][Full Text] [Related]
12. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
13. Intravenous pulses of methylprednisolone for systemic lupus erythematosus.
Badsha H; Edwards CJ
Semin Arthritis Rheum; 2003 Jun; 32(6):370-7. PubMed ID: 12833245
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis in systemic lupus erythematosus.
Gontero RP; Bedoya ME; Benavente E; Roverano SG; Paira SO
Reumatol Clin; 2015; 11(3):151-5. PubMed ID: 25441491
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone in systemic lupus erythematosus.
Howe HS; Boey ML; Feng PH
Singapore Med J; 1990 Feb; 31(1):18-21. PubMed ID: 2333537
[TBL] [Abstract][Full Text] [Related]
16. MDR1(ABCB1) gene polymorphisms associated with steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus.
Yang XY; Xu DH
Pharmazie; 2007 Dec; 62(12):930-2. PubMed ID: 18214345
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose methylprednisolone infusion on polymorphonuclear leukocyte function in patients with systemic lupus erythematosus.
Perez HD; Kimberley RP; Kaplan HB; Edelson H; Inman RD; Goldstein IM
Arthritis Rheum; 1981 May; 24(5):641-7. PubMed ID: 6263290
[TBL] [Abstract][Full Text] [Related]
18. High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus.
Kuroda T; Tanabe N; Wakamatsu A; Takai C; Sato H; Nakatsue T; Wada Y; Nakano M; Narita I
Clin Rheumatol; 2015 Dec; 34(12):2071-7. PubMed ID: 26384821
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of femoral head in SLE patient after short period of corticosteroid therapy--a case report.
Memon S; Rab SM
J Pak Med Assoc; 1991 Aug; 41(8):197-8. PubMed ID: 1942485
[No Abstract] [Full Text] [Related]
20. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus.
Parker BJ; Bruce IN
Lupus; 2007; 16(6):387-93. PubMed ID: 17664228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
